RadNet, Inc. (RDNT) News
Track canonical SquawkNews coverage tagged to RDNT, RadNet, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Truist Securities Maintains Buy on RadNet, Raises Price Target to $94
Truist Securities analyst David Macdonald maintains RadNet (NASDAQ: RDNT ) with a Buy and raises the price target from $90 to $94.
EQUITY | Aug 11, 2026, 05:35 PM UTC
L
RDNT deephealth receives FDA clearance for AI-powered breast ultrasound
RDNT deephealth receives FDA clearance for AI-powered breast ultrasound
REGULATION | Jul 30, 2026, 08:15 PM UTC
L
RDNT PRBA Medicare Physician Fee Schedule proposal for 2027, seems directionally positive for RDNT and PRVA @ KEYB
RDNT PRBA Medicare Physician Fee Schedule proposal for 2027, seems directionally positive for RDNT and PRVA @ KEYB
EQUITY | Jul 15, 2026, 11:18 AM UTC
M
RDNT Receives FDA Clearances
RDNT's DeepHealth receives two FDA clearances to add cardiovascular insights and prior exam integration to its AI-powered breast suite
EQUITY | Jun 25, 2026, 10:00 AM UTC